EC
EcoR1 Capital Portfolio holdings
AUM
$1.69B
This Quarter Return
-15.59%
1 Year Return
+7.54%
3 Year Return
+113.08%
5 Year Return
+306.58%
10 Year Return
+4,328.75%
AUM
$869M
AUM Growth
+$869M
(-10%)
Cap. Flow
+$137M
Cap. Flow
% of AUM
15.76%
Top 10 Holdings %
Top 10 Hldgs %
61.15%
Holding
62
New
17
Increased
11
Reduced
13
Closed
12
Top Buys
| 1 |
argenx
ARGX
|
$79.3M |
| 2 |
Xencor
XNCR
|
$35.8M |
| 3 |
Ionis Pharmaceuticals
IONS
|
$35.3M |
| 4 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$27.5M |
| 5 |
Solid Biosciences
SLDB
|
$23.2M |
Top Sells
| 1 |
MacroGenics
MGNX
|
$31.8M |
| 2 |
Ascendis Pharma
ASND
|
$25.5M |
| 3 |
FibroGen
FGEN
|
$22.8M |
| 4 |
Scholar Rock
SRRK
|
$20.5M |
| 5 |
Ultragenyx Pharmaceutical
RARE
|
$19.4M |
Sector Composition
| 1 | Healthcare | 89.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RUBY
26
DELISTED
Rubius Therapeutics, Inc
RUBY
| $9.52M | 0.95% |
592,128
| – | – |
|
|
ARRY
27
DELISTED
Array Biopharma Inc
ARRY
| $9.18M | 0.92% |
+644,002
| New | +$9.18M |
|
28
Prothena Corp
PRTA
$452M
| $8.63M | 0.86% |
+838,219
| New | +$8.63M |
|
29
Dianthus Therapeutics
DNTH
$781M
| $7.86M | 0.79% |
86,218
-9,913
| -10% | -$904K |
|
|
IMDZ
30
DELISTED
Immune Design Corp.
IMDZ
| $7.28M | 0.73% |
5,603,191
+3,361,291
| +150% | +$4.37M |
|
31
Rocket Pharmaceuticals
RCKT
$358M
| $6.67M | 0.67% |
+450,000
| New | +$6.67M |
|
32
CRISPR Therapeutics
CRSP
$4.82B
| $5.97M | 0.6% |
208,850
-291,150
| -58% | -$8.32M |
|
33
Neurogene
NGNE
$284M
| $4.89M | 0.49% |
113,294
| – | – |
|
|
PTLA
34
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $4.84M | 0.48% |
+247,858
| New | +$4.84M |
|
35
Aclaris Therapeutics
ACRS
$223M
| $4.54M | 0.45% |
+613,728
| New | +$4.54M |
|
|
FPRX
36
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $3.04M | 0.3% |
+326,775
| New | +$3.04M |
|
37
Corcept Therapeutics
CORT
$7.52B
| $2.22M | 0.22% |
+166,005
| New | +$2.22M |
|
38
Curis
CRIS
$21.5M
| $2.06M | 0.21% |
+149,110
| New | +$2.06M |
|
39
Dynavax Technologies
DVAX
$1.19B
| $1.28M | 0.13% |
+140,118
| New | +$1.28M |
|
|
CHMA
40
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $1.18M | 0.12% |
379,753
| – | – |
|
41
Corvus Pharmaceuticals
CRVS
$419M
| $1.08M | 0.11% |
295,420
-55,981
| -16% | -$205K |
|
42
Traws Pharma
TRAW
$11.4M
| $893K | 0.09% |
1,129
-204
| -15% | -$161K |
|
43
Arvinas
ARVN
$580M
| $643K | 0.06% |
50,000
| – | – |
|
|
AFMD
44
DELISTED
Affimed
AFMD
| $492K | 0.05% |
+15,822
| New | +$492K |
|
|
CNST
45
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $318K | 0.03% |
79,194
-200,806
| -72% | -$806K |
|
46
ProQR Therapeutics
PRQR
$256M
| $174K | 0.02% |
+11,022
| New | +$174K |
|
|
47
MacroGenics
MGNX
$121M
| – | – |
-1,481,086
| Closed | -$31.8M |
|
48
Mersana Therapeutics
MRSN
$34.8M
| – | – |
-19,825
| Closed | -$4.96M |
|
49
Nektar Therapeutics
NKTR
$543M
| – | – |
0
| – | – |
|
|
50
Ultragenyx Pharmaceutical
RARE
$3.04B
| – | – |
-254,000
| Closed | -$19.4M |
|